It is a pharma private limited company based in Pune, Maharashtra, India, established in 2020.
2020 | Pune, Maharashtra, India | ActiveNurix Pharmaceuticals India Private Limited, a active private limited company, was established on 22 July 2020 in Pune, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230PN2020PTC192256. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
Its leadership includes Amol Atulappa Nagapure (Additional Director), Pravin Mane (Additional Director), Anjali Sakharam Biradar (Director). It holds ₹1.20 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H No 20 Sr No10/3/1 Minu Mehta Soc Saswad Road Yewalewadi Pune Pune Mh 411048 In, Pune, Maharashtra, 411048.
U24230PN2020PTC192256
192256
22 July 2020
₹0.10 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Nurix Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amol Atulappa Nagapure | Additional Director | 01 Jul 2022 | Current |
| Pravin Mane | Additional Director | 01 Jul 2022 | Current |
| Anjali Sakharam Biradar | Director | 22 Jul 2020 | Current |
| Sheetal Shivling Bidve | Director | 22 Jul 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nurix Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 118.45% increase. The company also saw a substantial improvement in profitability, with a 193.03% increase in profit. The company's net worth Soared by an impressive increase of 41.34%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Nurix Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,200,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Jun 2024 | State Bank Of India | ₹1.20 M | Open |
Explore comprehensive loan charge details -
Nurix Pharmaceuticals India has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nurix Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nurix Pharmaceuticals India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Nurix Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on A charge with State Bank Of India of Rs. 1.20 M registered on 20 Jun 2024 with Charge ID 100951310 was modified on 05 Aug 2025. was documented.
Progress on Nurix Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was documented.
Progress on A charge with State Bank Of India amounted to Rs. 1.20 M with Charge ID 100951310 was registered on 20 Jun 2024. was documented.
The activity Amol Atulappa Nagapure was appointed as a Additional Director was appointed as a Additional Director on 01 Jul 2022 & has been associated with this company since 3 years 5 months . was completed.
The activity Pravin Mane was appointed as a Additional Director was appointed as a Additional Director on 01 Jul 2022 & has been associated with this company since 3 years 5 months . was completed.
The CIN of Nurix Pharmaceuticals India Private Limited is U24230PN2020PTC192256.
Nurix Pharmaceuticals India Private Limited is headquartered at H No 20 Sr No10/3/1 Minu Mehta Soc Saswad Road Yewalewadi Pune Pune Mh 411048 In, Pune, Maharashtra, 411048.
Nurix Pharmaceuticals India Private Limited was incorporated on 22 July 2020.
The current directors of Nurix Pharmaceuticals India Private Limited are
The primary industry of Nurix Pharmaceuticals India Private Limited is Manufacturing.
Nurix Pharmaceuticals India Private Limited is unlisted.
The authorized capital of Nurix Pharmaceuticals India Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX